Cargando…
Erratum to pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264349/ https://www.ncbi.nlm.nih.gov/pubmed/34295695 http://dx.doi.org/10.21037/tlcr-2021-3 |
Ejemplares similares
-
Pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report
por: Schiopu, Sanziana R. I., et al.
Publicado: (2021) -
Primary malignant mesothelioma of the diaphragm with liver invasion: A case report and review of literature: Erratum
Publicado: (2019) -
Erratum to: Evaluation of gene expression levels in the diagnosis of lung adenocarcinoma and malignant pleural mesothelioma
por: Ömeroğlu Şimşek, Gökçen, et al.
Publicado: (2022) -
Erratum: Multidetector CT Findings and Differential Diagnoses of Malignant Pleural Mesothelioma and Metastatic Pleural Diseases in Korea
por: Kim, Yoon Kyung, et al.
Publicado: (2016) -
Erratum to: ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms
por: Morré, D. James, et al.
Publicado: (2016)